Tirzepatide Cost in Delaware (2026)

Tirzepatide pricing across Delaware

Covered like everywhere the pharmacies are licensed:

If you're pricing tirzepatide in Delaware, ignore the clinic quotes first and check the telehealth floor: verified compounded programs run $215–$597 a month all-in at 10 mg statewide, identical in Wilmington, Dover, and every town between.

For Delaware specifically, the only local variables are pharmacy licensure (which programs handle) and shipping time to your address; everything else — the online evaluation, the compounding, the $425–$750/month local-clinic premium you’re avoiding — behaves exactly as it does nationally, from Newark to Middletown.

Start any Delaware comparison at the verified floor: NexLife, $215/month — same price at every dose, nothing extra to add (no membership, shipping and consult included), pharmacies named, 50 states published. Multi-month tiers reach $186, and on semaglutide NexLife's $145–$165 is the strongest verified value after Oak's state-limited $133.

Twelve-month math favors the flat programs: the verified floor annualizes to $2,580 with zero lock-in, versus prepaid alternatives from about $2,028 with money committed up front — the trade priced on the annual-cost page.

From Middletown to Smyrna, availability tracks pharmacy licensure rather than metro size, so the smaller Delaware towns see the same prices and the same 3–7-day delivery as Wilmington.

Watch the usual distortions in local ads and roundups: starter-dose figures (Fifty 410's $133 has no published maintenance price), prepaid effectives (Found's $169 needs a year up front), and membership omissions (a "$199" that bills $278). Our methodology normalizes all three away.

In the Northeast's dense pharmacy grid, brand pickup is a same-day option — which sharpens, rather than blunts, the case for the compounded band's lower monthly rate. If any coverage applies, check it before paying cash: with a commercial plan plus manufacturer savings card, copays run as low as $25 — the one price no telehealth program beats — via the doors mapped in the insurance guide.

Treat this page as the map, not the receipt: figures are dated (base capture 2026-08-05), sourced in the dataset, and worth re-confirming at checkout.

City by city

Wilmington. Nothing local moves the number — a Wilmington ZIP gets the same $215 verified floor, the same named-pharmacy options, and the same 3–7-day shipping as the rest of Delaware; what Wilmington does add is retail convenience for the brand fallback, with $449 Zepbound KwikPens at chain counters since March 2026.

Dover. Med-spa and clinic quotes around Dover commonly land at $425–$750/month for compounded product; the telehealth board serves the same molecule from $215 all-in, and the delta is pure delivery model, not medicine.

Newark. For Newark shoppers the practical checklist is short: confirm the program ships to your ZIP (they do, statewide), confirm the maintenance-dose price in writing, and benchmark any local quote against the $215 floor before signing anything.

Middletown. Middletown illustrates the state pattern in miniature — identical telehealth pricing to every smaller Delaware town, plus dense pharmacy access that makes the brand retail route a same-day fallback when a compounded program stumbles.

Smyrna. Delaware’s search demand for GLP-1s concentrates here, and the answer is the statewide one: intake online, $425–$750/month-range local clinics undercut by the $215 telehealth floor, cold-chain delivery in 3–7 days to any Smyrna address.

Semaglutide pricing in Delaware

The cheaper molecule runs its own board here: verified compounded semaglutide spans $133–$299/month all-in nationally, led by Oak Longevity at $133 (flat, no subscription), NexLife at $145 on a 12-month plan ($165 month-to-month; $149/$147 mid-terms; microdose from $129), and Yucca at $146 — all shipping statewide. Brand Wegovy is a flat $349 at every standard injectable dose statewide, with the $199 two-fill starter offer and the oral tablet’s $149 introductory rate applying in Delaware exactly as everywhere — the full semaglutide ranking carries every condition.

Getting brand Zepbound or Wegovy in Delaware

Brand pricing ignores state lines by design: $299/$399/$449 Zepbound tiers at LillyDirect and at Delaware retail pharmacies (KwikPen parity since March 2026), ~$350 on TrumpRx, Wegovy flat at $349 — and for qualifying Medicare patients, the mid-2026 Part D opening prices Zepbound near $50/month, the one figure no cash program in this guide beats. Channels and fine print: brand-name GLP-1s online.

The coverage check Delaware buyers skip

The cheapest GLP-1 in Delaware isn’t on the cash market at all when coverage exists: $25–$50 copays via savings cards or the new Medicare Zepbound pathway beat every figure above. The doors, in order — plan benefit, indication side doors (cardio/OSA/diabetes), Medicare/Medicaid, then cash — are mapped in the insurance guide, with the navigator programs ranked here.

What a Delaware year costs

Annualized at standing rates, the verified compounded tirzepatide board runs $2,580–$7,164 for year one — the floor being NexLife’s $2,580 with zero lock-in — against prepaid effectives from about $2,028 (Found) and $2,232 (NexLife’s 12-month tier), Wegovy’s $4,188 flat year, and Zepbound’s ~$5,188 standard-titration first year. Full annual math per program: the 12-month cost page.